Literature DB >> 21775976

Neuroimaging evidence of altered fronto-cortical and striatal function after prolonged cocaine self-administration in the rat.

Alessandro Gozzi1, Michela Tessari, Lisa Dacome, Federica Agosta, Stefano Lepore, Anna Lanzoni, Patrizia Cristofori, Emilio M Pich, Mauro Corsi, Angelo Bifone.   

Abstract

Cocaine addiction is often modeled in experimental paradigms where rodents learn to self-administer (SA) the drug. However, the extent to which these models replicate the functional alterations observed in clinical neuroimaging studies of cocaine addiction remains unknown. We used magnetic resonance imaging (MRI) to assess basal and evoked brain function in rats subjected to a prolonged, extended-access cocaine SA scheme. Specifically, we measured basal cerebral blood volume (bCBV), an established correlate of basal metabolism, and assessed the reactivity of the dopaminergic system by mapping the pharmacological MRI (phMRI) response evoked by the dopamine-releaser amphetamine. Cocaine-exposed subjects exhibited reduced bCBV in fronto-cortical areas, nucleus accumbens, ventral hippocampus, and thalamus. The cocaine group also showed an attenuated functional response to amphetamine in ventrostriatal areas, an effect that was significantly correlated with total cocaine intake. An inverse relationship between bCBV in the reticular thalamus and the frontal response elicited by amphetamine was found in control subjects but not in the cocaine group, suggesting that the inhibitory interplay within this attentional circuit may be compromised by the drug. Importantly, histopathological analysis did not reveal significant alterations of the microvascular bed in the brain of cocaine-exposed subjects, suggesting that the imaging findings cannot be merely ascribed to cocaine-induced vascular damage. These results document that chronic, extended-access cocaine SA in the rat produces focal fronto-cortical and striatal alterations that serve as plausible neurobiological substrate for the behavioral expression of compulsive drug intake in laboratory animals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775976      PMCID: PMC3194070          DOI: 10.1038/npp.2011.129

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  81 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Increased motivation for self-administered cocaine after escalated cocaine intake.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neuroreport       Date:  2003-12-02       Impact factor: 1.837

3.  Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course.

Authors:  Adam J Schwarz; Torsten Reese; Alessandro Gozzi; Angelo Bifone
Journal:  Magn Reson Imaging       Date:  2003-12       Impact factor: 2.546

4.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

Authors:  Scott A Small; Monica K Chawla; Michael Buonocore; Peter R Rapp; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

5.  Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain.

Authors:  Adam Schwarz; Alessandro Gozzi; Torsten Reese; Simone Bertani; Valerio Crestan; Jim Hagan; Christian Heidbreder; Angelo Bifone
Journal:  Synapse       Date:  2004-10       Impact factor: 2.562

6.  Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI.

Authors:  F Hyder; I Kida; K L Behar; R P Kennan; P K Maciejewski; D L Rothman
Journal:  NMR Biomed       Date:  2001 Nov-Dec       Impact factor: 4.044

7.  Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents.

Authors:  Y C Chen; J B Mandeville; T V Nguyen; A Talele; F Cavagna; B G Jenkins
Journal:  J Magn Reson Imaging       Date:  2001-11       Impact factor: 4.813

8.  Brain lesions induced by chronic cocaine administration to rats.

Authors:  Rosario Barroso-Moguel; Marisela Mendez-Armenta; Juana Villeda-Hernandez; Concepcion Nava-Ruiz; Abel Santamaria
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

Review 9.  Glutamate systems in cocaine addiction.

Authors:  Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

10.  Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

Authors:  Diana Martinez; Allegra Broft; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Audrey Perez; W Gordon Frankle; Thomas Cooper; Herbert D Kleber; Marian W Fischman; Marc Laruelle; W Gordon Frankel
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

View more
  20 in total

Review 1.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

2.  Dorsolateral striatal miR-134 modulates excessive methamphetamine intake in self-administering rats.

Authors:  Jing-Jing Shi; Dan-Ni Cao; Hui-Fen Liu; Zhi-Yuan Wang; Guan-Yi Lu; Ning Wu; Wen-Hua Zhou; Jin Li
Journal:  Metab Brain Dis       Date:  2019-06-01       Impact factor: 3.584

3.  Error processing and gender-shared and -specific neural predictors of relapse in cocaine dependence.

Authors:  Xi Luo; Sheng Zhang; Sien Hu; Sarah R Bednarski; Emily Erdman; Olivia M Farr; Kwang-Ik Hong; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li
Journal:  Brain       Date:  2013-03-12       Impact factor: 13.501

Review 4.  Synaptic mechanisms underlying persistent cocaine craving.

Authors:  Marina E Wolf
Journal:  Nat Rev Neurosci       Date:  2016-05-06       Impact factor: 34.870

5.  phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol-preferring from genetically heterogenous rats.

Authors:  A Bifone; A Gozzi; A Cippitelli; A Matzeu; E Domi; H Li; G Scuppa; N Cannella; M Ubaldi; F Weiss; R Ciccocioppo
Journal:  Addict Biol       Date:  2018-10-17       Impact factor: 4.280

6.  Longitudinal Changes in Brain Metabolic Activity after Withdrawal from Escalation of Cocaine Self-Administration.

Authors:  Céline Nicolas; Clovis Tauber; François-Xavier Lepelletier; Sylvie Chalon; Pauline Belujon; Laurent Galineau; Marcello Solinas
Journal:  Neuropsychopharmacology       Date:  2017-05-29       Impact factor: 7.853

Review 7.  Chronic cocaine disrupts mesocortical learning mechanisms.

Authors:  William C Buchta; Arthur C Riegel
Journal:  Brain Res       Date:  2015-02-20       Impact factor: 3.252

8.  Cerebellar neuronal apoptosis in heroin-addicted rats and its molecular mechanism.

Authors:  Hongwei Pu; Xuemei Wang; Jianlong Zhang; Chuang Ma; Yinxia Su; Xiujuan Li; Xiaoshan Liu; Liping Su
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

9.  Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine.

Authors:  Alessandro Gozzi; Stefano Lepore; Elena Vicentini; Emilio Merlo-Pich; Angelo Bifone
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

10.  Reduced limbic metabolism and fronto-cortical volume in rats vulnerable to alcohol addiction.

Authors:  Alessandro Gozzi; Federica Agosta; Maurizio Massi; Roberto Ciccocioppo; Angelo Bifone
Journal:  Neuroimage       Date:  2012-12-20       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.